Immortalized Human Kidney Fibroblasts (IM-HKF) provided by Innoprot have been developed by immortalizing primary human healthy kidney fibroblasts with SV40 Large T antigen.
Immortalized cells were controlled passaging side by side with the primary cells. Primary cells go into senescence after the 4th passage while the SV40‐tranduced cells go beyond 30 passages.
Each vial of Immortalized Human Kidney Fibroblasts contains more than 1 million viable cells. Innoprot also offers optimized medium and reagents for the growth of IM-HKF which are quality tested together and guaranteed to give maximum performance as a global solution for in vitro IM-HKF culture.
Immortalized Human Kidney Podocytes (IM-HKP) provided by Innoprot have been developed by immortalizing primary human healthy kidney podocytes with SV40 Large T antigen.
Immortalized cells were controlled passaging side by side with the primary cells. Primary cells go into senescence after the 4th passage while the SV40‐tranduced cells go beyond 30 passages.
Each vial of Immortalized Human Kidney Podocytes contains more than 1 million viable cells. Innoprot also offers optimized medium and reagents for the growth of IM-HKP which are quality tested together and guaranteed to give maximum performance as a global solution for in vitro IM-HPK culture.
Immortalized Human Meningeal Cells (IM-HMnC) provided by Innoprot have been developed by immortalizing primary human healthy meningeal cells with SV40 Large T antigen.
Immortalized cells were controlled passaging side by side with the primary cells. Primary cells go into senescence after the 4th passage while the SV40‐tranduced cells go beyond 30 passages.
Each vial of Immortalized Human Meningeal Cells contains more than 1 million viable cells. Innoprot also offers optimized medium and reagents for the growth of IM-MnC which are quality tested together and guaranteed to give maximum performance as a global solution for in vitro IM-HMnC culture.
Immortalized Human Microglia (IM-HM) provided by Innoprot have been developed by immortalizing primary human microglia with SV40 Large T antigen.
Immortalized cells were controlled passaging side by side with the primary cells. These primary cells go into senescence after the 2nd passage while the SV40‐tranduced cells go beyond 30 passages.
Each vial of Immortalized Human Microglia contains more than 1 million viable cells. Innoprot also offers optimized medium and reagents for the growth of IM-HM which are quality tested together and guaranteed to give maximum performance as a global solution for in vitro IM-HM culture.
Immortalized Human Pancreatic Stromal Cells (IM-HPanSC) provided by Innoprot have been developed by immortalizing primary human pancreatic stromal cells with SV40 Large T antigen.
Immortalized cells were controlled passaging side by side with the primary cells. Primary cells go into senescence after the 3th passage while the SV40‐tranduced cells go beyond 30 passages.
Each vial of IM-HPanSC contains more than 1 million viable cells. Innoprot also offers optimized medium and reagents for the growth of IM-HPanSC which are quality tested together and guaranteed to give maximum performance as a global solution for in vitro IM-HPanSC culture.
Immortalized Human Renal Mesangial Cells (IM-HRMC) provided by Innoprot have been developed by immortalizing primary human healthy renal mesangial cells with SV40 Large T antigen.
Immortalized cells were controlled passaging side by side with the primary cells. Primary cells go into senescence after the 4th passage while the SV40‐tranduced cells go beyond 30 passages.
Each vial of Immortalized Human Renal Mesangial Cells contains more than 1 million viable cells. Innoprot also offers optimized medium and reagents for the growth of IM-HRMC which are quality tested together and guaranteed to give maximum performance as a global solution for in vitro IM-HRMC culture.
Immortalized Human Retinal Endothelial Cells (IM-HREC) provided by Innoprot have been developed by immortalizing primary human retinal endothelial cells with SV40 Large T antigen.
Immortalized cells were controlled passaging side by side with the primary cells. Primary cells go into senescence after the 4th passage while the SV40‐tranduced cells go beyond 30 passages.
Each vial of IM-HREC contains more than 1 million viable cells. Innoprot also offers optimized medium and reagents for the growth of IM-HREC which are quality tested together and guaranteed to give maximum performance as a global solution for in vitro IM-HREC culture.
Immortalized Human Small Intestine Fibroblasts (IM-HSIF) provided by Innoprot have been developed by immortalizing primary human healthy small intesine fibroblasts with SV40 Large T antigen.
Immortalized cells were controlled passaging side by side with the primary cells. Primary cells go into senescence after the 4th passage while the SV40‐tranduced cells go beyond 30 passages.
Each vial of Immortalized Human Small Intestine Fibroblasts contains more than 1 million viable cells. Innoprot also offers optimized medium and reagents for the growth of IM-HSIF which are quality tested together and guaranteed to give maximum performance as a global solution for in vitro IM-HSIF culture.
Immortalized Human Synoviocytes (IM-HS) provided by Innoprot have been developed by immortalizing primary human synoviocytes isolated from healthy human synovial tissue with SV40 Large T antigen.
Immortalized cells were controlled passaging side by side with the primary cells. Primary cells go into senescence after the 3rd passage while the SV40‐tranduced cells go beyond 30 passages.
Each vial of Immortalized Human Synoviocytes contains more than 1 million viable cells. Innoprot also offers optimized medium and reagents for the growth of IM-HS which are quality tested together and guaranteed to give maximum performance as a global solution for in vitro IM-HS culture.
Immortalized Human Tenocytes (IM-HT) provided by Innoprot have been developed by immortalizing primary human tenocytes isolated from patellar tendon with SV40 Large T antigen.
Immortalized cells were controlled passaging side by side with the primary cells. Primary cells go into senescence after the 4th passage while the SV40‐tranduced cells go beyond 30 passages.
Each vial of Immortalized Human Tenocytes contains more than 1 million viable cells. Innoprot also offers optimized medium and reagents for the growth of IM-HT which are quality tested together and guaranteed to give maximum performance as a global solution for in vitro IM-HT culture.
